NIH researchers identify avenue for enhanced GLP-1-induced weight loss

1

NIH researchers have identified intracellular signaling processes linked to the weight-loss effects of GLP-1 receptor agonists in mice.
2

The study found that increased levels of cyclic adenosine monophosphate (cAMP) in the area postrema are crucial for the weight-loss effects of semaglutide.
3

Responses to semaglutide varied among neurons, with some maintaining elevated cAMP levels while others experienced temporary increases.
4

Inhibiting the enzyme PDE4 with roflumilast showed potential to extend the effects of GLP-1s and reduce the frequency of drug administration.
5

Future research aims to explore the intracellular effects of GLP-1s over longer periods using advanced techniques.

1